Good news: The Supreme Court rejected a challenge from anti-abortion doctors to the drug mifepristone, ensuring abortion pills remain widely available for now.
dismissing the case that the anti-abortion doctors who brought the challenge lacked standing. This means that for now, abortion pills will remain widely available for people who need them and will not be subject toThis has made abortion opponents and supporters deeply invested in whether people can access the medications.
Despite the Court’s decision, the fight over abortion pills is far from over.
The leader of the Catholic church is reportedly still saying the same word he had to apologize for two weeks ago.Kendall Jenner and Bad Bunny Are Going Back for Seconds*Sorry, there was a problem signing you up.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Supreme Court rejects bid to restrict access to abortion pillLawrence Hurley covers the Supreme Court for NBC News.
Read more »
Supreme Court sends dispute over Arkansas' GOP-drawn congressional map back to lower courtLawrence Hurley covers the Supreme Court for NBC News.
Read more »
NY court upholds mandatory abortion coverage; Albany diocese plans Supreme Court appealALBANY, N.Y. (AP) New York can continue to require companies with health insurance plans to cover medically necessary abortions, the state's highest court rule
Read more »
Supreme Court preserves abortion pill access, rejecting mifepristone challengeThe Supreme Court on Thursday tossed out a challenge targeting the availability of a widely used abortion pill, preserving access to the drug.
Read more »
Abortion pill access is unchanged after the Supreme Court's decision. Here's what you need to knowA unanimous Supreme Court ruling means the abortion pill mifepristone remains available, including via mail delivery.
Read more »
Unanimous Supreme Court preserves access to widely used abortion medicationThe justices ruled that abortion opponents lacked the legal right to sue over the federal Food and Drug Administration’s approval of the medication, mifepristone, and the FDA’s subsequent actions to ease access to it.
Read more »